Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's demand for sensitive information.
This rejection became public after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative later stated that the United States was requesting genetic material for scientific study and profit but refused to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further talks to secure a agreement acceptable to both sides so the nation's vital HIV programme can be sustained.
Broader Implications
This development follows a comparable case in neighbouring Kenya, where a high court blocked a similar deal with the US following concerns were filed about the security of citizens' health data.
After returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
Based on reports, 16 African countries have to date signed these new agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population if a new disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting structures already set up through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This system is intended to ensure that when a country contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We encourage continued discussions with our American counterparts on how future collaboration could be designed in a way that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that negotiations need to persist since much of the nation's Aids initiatives were funded by external financing.
"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," it added.
This impasse highlights the continuing debate between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.